Thursday, April 17, 2014 10:24:00 AM
Common stock, par value $.001, 6,000,000,000 shares authorized, 5,071,165,583 and 5,678,216,649 shares issued and outstanding at June 30, 2013 and December 31, 2013, respectively
5,071,164 5,678,215
Additional paid in capital
193,761,159 193,807,817
Deferred Compensation
(28,305 ) -
Deficit accumulated during development stage
(203,691,541 ) (204,409,339 )
Less-Treasury stock, 13,750 shares at cost
(7,973 ) (7,973 )
TOTAL STOCKHOLDERS' DEFICIT
$ (4,895,496 ) $ (4,931,280 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
What the frak how lol.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM